High-priced specialty drugs spur calls for competition

High-priced specialty drugs spur calls for competition

WASHINGTON – Staggering price tags for new drugs that treat a small number of patients could threaten the affordability of all prescription medicine, a major patient advocacy group said Thursday. “Prices are way too high, much higher than they need to be,” said...